| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |